Early Whole-Body Diffusion-weighted MRI Helps Predict Long-term Outcome Following Peptide Receptor Radionuclide Therapy for Metastatic Neuroendocrine TumorsVincent Vandecaveye, Christophe M. Deroose, Ragna Vanslembrouck et al.|Radiology Imaging Cancer|2022Cited by 7
The EXTENT Study: Results From an International Expert Delphi Consensus to Define Ultrasonographic Parameters for Measuring Bowel Damage in Crohn’s DiseaseCarolina Palmela, Bram Verstockt, Joana Torres et al.|Clinical Gastroenterology and Hepatology|2025Cited by 3